Trials / Completed
CompletedNCT01627977
Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy
A Descriptive Study to Evaluate the Effectiveness of the Dye Compound of the Combination of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Federal University of São Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to test the efficacy of the combination of dye Lutein, Zeaxanthin and brilliant blue to stain the internal limiting membrane as well as the epiretinal membranes during the Vitrectomy surgery.
Detailed description
Twenty five patients with epiretinal membrane, macular hole or proliferative diabetic retinopathy and indication of vitrectomy surgery will be selected to participate in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dye of Lutein, Zeaxanthin and Brilliant Blue | dye composed of Lutein, Zeaxanthin and Brilliant Blue will be used during the vitrectomy surgery to dye the membranes |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-01-01
- Completion
- 2014-03-01
- First posted
- 2012-06-26
- Last updated
- 2016-03-16
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01627977. Inclusion in this directory is not an endorsement.